Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | PLOD2 | O00469 | 2/20 | 0.43 |
| ▸ | PLOD3 | O60568 | 2/20 | 0.43 |
| ▸ | PLOD1 | Q02809 | 2/20 | 0.43 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.43 |
| ▸ | FEN1 | P39748 | 1/20 | 0.43 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenanthroline SCHEMBL6888855 | 1.00 | MEN1 (0.47) | MEN1KMT2AKDM4ENPSR1ALOX15 | |
| Phenanthroline SCHEMBL3137857 | 0.99 | KDM4E (0.48) | MEN1KMT2AKDM4ENPSR1ALOX15 | |
| SCHEMBL27857016 | 0.90 | LMNA (0.48) | MEN1KMT2AKDM4ENPSR1ALOX15 | |
| SCHEMBL28926537 | 0.90 | LMNA (0.48) | MEN1KMT2AKDM4ENPSR1ALOX15 | |
| SCHEMBL3800916 | 0.84 | ERCC5 (0.57) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL1681119 | 0.84 | ERCC5 (0.57) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL195358 | 0.83 | ERCC5 (0.59) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL11555244 | 0.81 | ERCC5 (0.57) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL9566088 | 0.81 | ERCC5 (0.57) | MEN1KMT2AKDM4EMAPTALDH1A1 | |
| SCHEMBL10631235 | 0.81 | ERCC5 (0.57) | MEN1KMT2AKDM4EMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060152165-A1 | Method of driving an electroluminescent device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2006-07-13 | — | — | US | claimed |
| EP-1423838-A2 | METHOD OF DRIVING AN ELECTROLUMINESCENT DEVICE | Isis Innovation Limited (GB) | 2004-06-02 | — | — | EP | claimed |
| WO-2003021563-A2 | METHOD OF DRIVING AN ELECTROLUMINESCENT DEVICE | ISIS INNOVATION LIMITED (GB) | 2003-03-13 | — | — | WO | claimed |
| CN-110226239-B | Charge-transporting varnish and charge-transporting film using same | 日产化学株式会社 | 2022-08-09 | — | — | CN | disclosed |
| US-9825239-B2 | Benzindolocarbazole derivative, light-emitting element material produced using same, and light-emitting element | TORAY INDUSTRIES, INC. (JP) | 2017-11-21 | — | — | US | disclosed |
| US-9627625-B2 | Light-emitting device material and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2017-04-18 | — | — | US | disclosed |
| US-9391288-B2 | Light emitting device material and light emitting device | TORAY INDUSTRIES, INC. (JP) | 2016-07-12 | — | — | US | disclosed |
| US-20150280140-A1 | Benzindolocarbazole Derivative, Light-Emitting Element Material Produced Using Same, and Light-Emitting Element | TORAY INDUSTRIES, INC. (JP) | 2015-10-01 | — | — | US | disclosed |
| US-20150084020-A1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2015-03-26 | — | — | US | disclosed |
| US-20140070204-A1 | LIGHT EMITTING DEVICE MATERIAL AND LIGHT EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2014-03-13 | — | — | US | disclosed |
| US-20130264558-A1 | LIGHT EMITTING DEVICE MATERIAL AND LIGHT EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2013-10-10 | — | — | US | disclosed |
| CN-100376033-C | Full-color display panel and light-splitting substrate thereof | RIT DISPLAY CORP (CN) | 2008-03-19 | — | — | CN | disclosed |
| US-7201975-B2 | Organic light emitting device | SANYO ELECTRIC CO., LTD. (JP) | 2007-04-10 | — | — | US | disclosed |
| US-20060152165-A1 | Method of driving an electroluminescent device | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2006-07-13 | — | — | US | disclosed |
| CN-1571606-A | Full-color display panel and light-splitting substrate thereof | RITDISPLAY CORP (CN) | 2005-01-26 | — | — | CN | disclosed |
| EP-1423838-A2 | METHOD OF DRIVING AN ELECTROLUMINESCENT DEVICE | Isis Innovation Limited (GB) | 2004-06-02 | — | — | EP | disclosed |
| WO-2003021563-A2 | METHOD OF DRIVING AN ELECTROLUMINESCENT DEVICE | ISIS INNOVATION LIMITED (GB) | 2003-03-13 | — | — | WO | disclosed |
| EP-1215945-A2 | Organic light emitting device | Sanyo Electric Co., Ltd. (JP) | 2002-06-19 | — | — | EP | disclosed |
| US-20020071963-A1 | Organic light emitting device | SANYO ELECTRIC CO., LTD. (JP) | 2002-06-13 | — | — | US | disclosed |
| US-6229505-B1 | Organic electroluminescent device and organic electroluminescent apparatus | SANYO ELECTRIC CO., LTD. (JP) | 2001-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150280140-A1 | Benzindolocarbazole Derivative, Light-Emitting Element Material Produced Using Same, and Light-Emitting Element | L3MBTL4, L3MBTL1, IL4I1 | MEN1 3128/4885KMT2A 1107/4885KDM4E 523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.